CD44 and neoplasm: As further evidence of the suitability of our 3-D cultures to interrogate novel treatment options to target GSCs, we observed, using Light Sheet Fluorescence Microscopy (LSFM) that the localisation of the CD133-positive and CD44-positive cells in each gliomasphere culture was unique and presumably reflected the different genetic background of the original tumours.